Similar Search Results - EconBiz

Les déterminants des fusions-acquisitions : le cas de l'industrie pharmaceutique

Duflos, Gautier; Pfister, Etienne - In: Revue économique : revue bimestrielle 58 (2007) 3, pp. 577-586

Persistent link: https://www.econbiz.de/10003459491

Two essays on derivatives

Demirer, Rıza - 2003

Persistent link: https://www.econbiz.de/10003385157

Does public scientific research complement private investment in research and development in the pharmaceutical industry?

Toole, Andrew A. - In: The journal of law & economics 50 (2007) 1, pp. 81-104

Persistent link: https://www.econbiz.de/10003506620

The impact of public basic research on industrial innovation : evidence from the pharmaceutical industry

Toole, Andrew A. - 2011 - This version: March 2011

While most economists believe that public scientific research fuels industry innovation and economic growth, systematic evidence supporting this relationship is surprisingly limited. In a recent study, Acemoglu and Linn (2004) identified market size as a significant driver of drug innovation in...

Persistent link: https://www.econbiz.de/10009374417

Do firms underinvest in long-term research? : evidence from cancer clinical trials

Budish, Eric B.; Roin, Benjamin N.; Williams, Heidi - In: The American economic review 105 (2015) 7, pp. 2044-2085

Persistent link: https://www.econbiz.de/10011327400

Count data stochastic frontier models, with an application to the patents-R&D relationship

Fé, Eduardo; Hofler, Richard A. - In: Journal of productivity analysis 39 (2013) 3, pp. 271-284

Persistent link: https://www.econbiz.de/10009749963

Do fixed patent terms distort innovation? : evidence from cancer clinical trials

Budish, Eric B.; Roin, Benjamin N.; Williams, Heidi - 2013

Persistent link: https://www.econbiz.de/10010193836

A Ricardian-demand explanation for changing pharmaceutical R&D productivity

Pauly, Mark V.; Myers, Kyle - 2016

Persistent link: https://www.econbiz.de/10011563034

Starving (or fattening) the golden goose? : generic entry and the incentives for early-stage pharmaceutical innovation

Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - 2014

Persistent link: https://www.econbiz.de/10010421600

When are assets compementary? : star scientists, strategic alliances, and innovation in the pharmaceutical industry

Hess, Andrew M.; Rothärmel, Frank T. - In: Strategic management journal 32 (2011) 8, pp. 895-909

Persistent link: https://www.econbiz.de/10009237567

1
2
3
4
5
6
7
8
9
10
Next
Last

A service of the